EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q4 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $129,000 | -18.9% | 27,802 | +31.0% | 0.00% | – |
Q1 2024 | $159,000 | -62.9% | 21,230 | -49.9% | 0.00% | – |
Q4 2023 | $429,000 | +30.0% | 42,351 | +0.3% | 0.00% | – |
Q3 2023 | $330,000 | +36.4% | 42,222 | +43.7% | 0.00% | – |
Q2 2023 | $242,000 | +50.3% | 29,378 | +32.4% | 0.00% | – |
Q1 2023 | $161,000 | -75.3% | 22,190 | -69.8% | 0.00% | – |
Q4 2022 | $652,000 | -30.3% | 73,455 | -3.8% | 0.00% | – |
Q3 2022 | $935,000 | +6.4% | 76,385 | +2.9% | 0.00% | – |
Q2 2022 | $879,000 | -39.8% | 74,231 | -3.4% | 0.00% | – |
Q1 2022 | $1,461,000 | -10.1% | 76,852 | +25.6% | 0.00% | – |
Q4 2021 | $1,626,000 | -23.5% | 61,168 | +18.2% | 0.00% | -100.0% |
Q3 2021 | $2,126,000 | -40.0% | 51,734 | -17.3% | 0.00% | 0.0% |
Q2 2021 | $3,541,000 | +67.2% | 62,525 | +24.0% | 0.00% | 0.0% |
Q1 2021 | $2,118,000 | -74.8% | 50,438 | -57.9% | 0.00% | -50.0% |
Q4 2020 | $8,407,000 | +381.5% | 119,895 | +92.7% | 0.00% | +100.0% |
Q3 2020 | $1,746,000 | -9.3% | 62,229 | -4.4% | 0.00% | 0.0% |
Q2 2020 | $1,926,000 | +66.6% | 65,086 | +11.6% | 0.00% | 0.0% |
Q1 2020 | $1,156,000 | -31.6% | 58,300 | +2.1% | 0.00% | 0.0% |
Q4 2019 | $1,691,000 | +13.3% | 57,115 | -13.0% | 0.00% | 0.0% |
Q3 2019 | $1,493,000 | -7.7% | 65,639 | +0.4% | 0.00% | 0.0% |
Q2 2019 | $1,618,000 | +7.8% | 65,400 | +6.5% | 0.00% | 0.0% |
Q1 2019 | $1,501,000 | +28.2% | 61,395 | +19.3% | 0.00% | 0.0% |
Q4 2018 | $1,171,000 | -32.0% | 51,482 | -4.9% | 0.00% | 0.0% |
Q3 2018 | $1,722,000 | -11.2% | 54,157 | +0.1% | 0.00% | 0.0% |
Q2 2018 | $1,939,000 | +55.5% | 54,116 | +43.9% | 0.00% | 0.0% |
Q1 2018 | $1,247,000 | +101.5% | 37,616 | +86.9% | 0.00% | – |
Q4 2017 | $619,000 | +85.9% | 20,122 | +45.2% | 0.00% | – |
Q3 2017 | $333,000 | +112.1% | 13,858 | +48.0% | 0.00% | – |
Q2 2017 | $157,000 | -21.9% | 9,364 | +4.1% | 0.00% | – |
Q1 2017 | $201,000 | +91.4% | 8,992 | +38.4% | 0.00% | – |
Q4 2016 | $105,000 | +162.5% | 6,496 | +118.1% | 0.00% | – |
Q3 2016 | $40,000 | +207.7% | 2,979 | +441.6% | 0.00% | – |
Q2 2016 | $13,000 | -92.1% | 550 | -88.4% | 0.00% | – |
Q1 2016 | $164,000 | – | 4,725 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 6,000,000 | $28,020,000 | 0.84% |
Knott David M Jr | 177,000 | $827 | 0.33% |
Integral Health Asset Management, LLC | 675,000 | $3,152,250 | 0.30% |
Avidity Partners Management LP | 816,000 | $3,810,720 | 0.16% |
Green Alpha Advisors, LLC | 30,267 | $141,347 | 0.11% |
PDT Partners, LLC | 246,537 | $1,151,328 | 0.11% |
Spectrum Planning & Advisory Services Inc. | 12,051 | $57,122 | 0.06% |
Woodline Partners LP | 970,491 | $4,532,193 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 168,371 | $786,293 | 0.04% |
Virtus ETF Advisers LLC | 16,489 | $77,004 | 0.04% |